A 34-year-old woman presents with excessive worry about multiple life domains for more than 6 months, difficulty controlling the worry, sleep disturbance, and muscle tension. There is no substance use and no major depressive episode. According to Canadian anxiety guidelines, which pharmacologic option is preferred as first-line?